Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients.
Yongjun LiMingming YangXi ChenRui ZhangJing LiXiaoguo ZhangPengfei ZuoGenshan MaPublished in: Journal of interventional cardiology (2022)
After 1 year of PCSK9 inhibition treatment for ACS patients, the area stenosis of non-TLR was considerably reduced.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- end stage renal disease
- ejection fraction
- newly diagnosed
- cardiovascular disease
- acute myocardial infarction
- peritoneal dialysis
- immune response
- heart failure
- type diabetes
- coronary artery bypass grafting
- left ventricular
- atrial fibrillation
- aortic valve
- smoking cessation
- transcatheter aortic valve replacement
- coronary artery bypass